This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Investigators from multiple institutions conducted a retrospective cohort study of children diagnosed with systemic onset juvenile idiopathic arthritis (SJIA) to assess disease course in the era of biologic disease-modifying antirheumatic drugs (BDMARDs). Patients were eligible if they were (a) diagnosed at the study children’s hospital with SJIA between 1996–2015, (b) had been evaluated within the first 6 months of disease onset, and (c) followed up for ≥6 months. Demographic and clinical data were obtained from participants’ charts, including symptoms at disease onset, disease course, and treatments used.
Disease course was categorized into 3 groups: (1) monophasic, defined as a single episode of disease; (2) polycyclic, characterized by recurrent flares; and (3) persistent, defined as still requiring medication at the last visit and with a disease course of flares …
Individual Login
Institutional Login
You may be able to gain access using your login credentials for your institution. Contact your librarian or administrator if you do not have a username and password.
Log in through your institution
Pay Per Article - You may access this article (from the computer you are currently using) for 2 days for US$25.00
Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.
In this issue
Related Articles
Cited By...
- No citing articles found.